{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:56:23Z","timestamp":1777874183994,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","award":["B.SUB.23.416"],"award-info":[{"award-number":["B.SUB.23.416"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115910","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T05:21:26Z","timestamp":1700803286000},"page":"115910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Sex-dependent effects of finerenone on hemostasis in normoglycemic and streptozotocin-induced diabetic mice"],"prefix":"10.1016","volume":"169","author":[{"given":"Bielicka","family":"Natalia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misztal","family":"Tomasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chabielska","family":"Ewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gromotowicz-Pop\u0142awska","family":"Anna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115910_bib1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/j.ajkd.2022.04.016","article-title":"Aldosterone, mineralocorticoid receptor activation, and CKD: a review of evolving treatment paradigms","volume":"80","author":"Epstein","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.biopha.2023.115910_bib2","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","article-title":"Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes","volume":"1","author":"Epstein","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2023.115910_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105859","article-title":"Nonsteroidal mineralocorticoid receptor antagonism for cardiovascular and renal disorders \u2212 new perspectives for combination therapy","volume":"172","author":"Kolkhof","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2023.115910_bib4","first-page":"122","article-title":"Rapid effects of aldosterone on platelets, coagulation, and fibrinolysis lead to experimental thrombosis augmentation","author":"Gromotowicz-Poplawska","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115910_bib5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1177\/1470320313515037","article-title":"Eplerenone reduces arterial thrombosis in diabetic rats","volume":"16","author":"Zakrzeska","year":"2015","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.biopha.2023.115910_bib6","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s40265-021-01599-7","article-title":"Finerenone: first approval","volume":"81","author":"Frampton","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2023.115910_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110908","article-title":"Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: the FINE-ONE trial","volume":"204","author":"Heerspink","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2023.115910_bib8","doi-asserted-by":"crossref","DOI":"10.5582\/irdr.2020.01008","article-title":"The cardiovascular outcomes of finerenone in patients with chronic kidney disease and type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"11","author":"Abdelazeem","year":"2022","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.biopha.2023.115910_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MJT.0b013e31816a61bb","article-title":"Acute ischemic coronary artery disease and ischemic stroke: similarities and differences","volume":"15","author":"Fisher","year":"2008","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.biopha.2023.115910_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5045\/br.2022.2021204","article-title":"Diabetes mellitus and diabetic nephropathy: a review of the literature on hemostatic changes in coagulation and thrombosis","volume":"57","author":"Alsharidah","year":"2022","journal-title":"Blood Res"},{"key":"10.1016\/j.biopha.2023.115910_bib11","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1016\/j.ekir.2022.08.022","article-title":"Underrepresentation of women in recent landmark kidney trials: the gender gap prevails","volume":"7","author":"Vinson","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.biopha.2023.115910_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1586\/17474086.1.1.3","article-title":"Sex differences in thrombosis","volume":"1","author":"Nordstrom","year":"2008","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.biopha.2023.115910_bib13","doi-asserted-by":"crossref","first-page":"C193","DOI":"10.1152\/ajpcell.00372.2022","article-title":"Emerging vascular cell-specific roles for mineralocorticoid receptor: implications for understanding sex differences in cardiovascular disease","volume":"324","author":"Wolter","year":"2023","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.biopha.2023.115910_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph0547s70","article-title":"Streptozotocin\u2010induced diabetic models in mice and rats","volume":"70","author":"Furman","year":"2015","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115910_bib15","unstructured":"Center for Drug Evaluation and Research. Application number: 215341Orig1s000 \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2021\/215341Orig1s000IntegratedR.pdf\u3009."},{"key":"10.1016\/j.biopha.2023.115910_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184888","article-title":"The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury","volume":"12","author":"Dutzmann","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115910_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/HYPERTENSIONAHA.117.10360","article-title":"Selective mineralocorticoid receptor cofactor modulation as molecular basis for finerenone\u2019s antifibrotic activity","volume":"71","author":"Grune","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2023.115910_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s40738-020-00074-3","article-title":"Staging of the estrous cycle and induction of estrus in experimental rodents: an update","volume":"6","author":"Ajayi","year":"2020","journal-title":"Fertil. Res. Pract."},{"key":"10.1016\/j.biopha.2023.115910_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-28225-8","article-title":"Sex-dependent effects of canagliflozin and dapagliflozin on hemostasis in normoglycemic and hyperglycemic mice","volume":"13","author":"Marci\u0144czyk","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115910_bib20","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.3390\/ijms22179611","article-title":"Utility of platelet endothelial cell adhesion molecule 1 in the platelet activity assessment in mouse and human blood","volume":"22","author":"Marcinczyk","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115910_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/07388551.2015.1128876","article-title":"Flow cytometry: basic principles and applications","volume":"37","author":"Adan","year":"2017","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.biopha.2023.115910_bib22","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1111\/bph.13178","article-title":"A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury","volume":"172","author":"Li","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115910_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.thromres.2016.04.018","article-title":"Bidirectional functions of thrombin on fibrinolysis: Evidence of thrombin-dependent enhancement of fibrinolysis provided by spontaneous plasma clot lysis","volume":"143","author":"Tomczyk","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.biopha.2023.115910_bib24","doi-asserted-by":"crossref","DOI":"10.5551\/jat.63382","article-title":"A selective mineralocorticoid receptor blocker, esaxerenone, attenuates vascular dysfunction in diabetic C57BL\/6 Mice","volume":"30","author":"Munkhjargal","year":"2023","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.biopha.2023.115910_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-8741(01)00246-X","article-title":"Traditional Indian anti-diabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice","volume":"76","author":"Grover","year":"2001","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2023.115910_bib26","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.3390\/ijms21238969","article-title":"Urinary metabolomic profiling in streptozotocin-induced diabetic mice after treatment with losartan","volume":"21","author":"Hyeon","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115910_bib27","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.0602956103","article-title":"Estrogens protect pancreatic \u03b2-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice","volume":"103","author":"Le May","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.115910_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","article-title":"Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: Molecular insights and therapeutic strategies","volume":"17","author":"Kaur","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115910_bib29","doi-asserted-by":"crossref","first-page":"13254","DOI":"10.3390\/ijms241713254","article-title":"PECAM-1\/thrombus ratio correlates with blood loss during off-pump coronary artery bypass grafting (OPCAB) surgery: a preliminary study","volume":"24","author":"Bielicka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115910_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/01.ATV.0000149675.83552.83","article-title":"Sulfatides activate platelets through P-selectin and enhance platelet and platelet\u2013leukocyte aggregation","volume":"25","author":"Merten","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2023.115910_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-019-0391-2","article-title":"The effect of mild agonist stimulation on the platelet reactivity in patients with type 2 diabetes mellitus","volume":"19","author":"Mahmoodian","year":"2019","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.biopha.2023.115910_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-023-01064-3","article-title":"Finerenone attenuates myocardial apoptosis, metabolic disturbance and myocardial fibrosis in type 2 diabetes mellitus","volume":"15","author":"Jin","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.biopha.2023.115910_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ajh\/hpac124","article-title":"The nonsteroidal mineralocorticoid-receptor-antagonist finerenone in cardiorenal medicine: A state-of-the-art review of the literature","volume":"36","author":"Georgianos","year":"2023","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.biopha.2023.115910_bib34","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1096\/fj.13-238188","article-title":"Endothelial mineralocorticoid receptor activation enhances endothelial protein C receptor and decreases vascular thrombosis in mice","volume":"28","author":"Lagrange","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2023.115910_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.steroids.2014.08.013","article-title":"Cardiac effects of aldosterone: does gender matter?","volume":"91","author":"Mihailidou","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.biopha.2023.115910_bib36","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/HYPERTENSIONAHA.122.19526","article-title":"Sex-related signaling of aldosterone\/mineralocorticoid receptor pathway in calcific aortic stenosis","volume":"79","author":"Matilla","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2023.115910_bib37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1752-8062.2009.00094.x","article-title":"Sex-specific impact of aldosterone receptor antagonism on ventricular remodeling and gene expression after myocardial infarction","volume":"2","author":"Kanashiro-Takeuchi","year":"2009","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.biopha.2023.115910_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/17512433.2022.2094770","article-title":"Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes","volume":"15","author":"Lerma","year":"2022","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115910_bib39","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/HYPERTENSIONAHA.119.12802","article-title":"Progesterone predisposes females to obesity-associated leptin-mediated endothelial dysfunction via upregulating endothelial MR (Mineralocorticoid Receptor) expression","volume":"74","author":"Faulkner","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2023.115910_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1246-7820(00)88980-6","article-title":"Vascular biosynthesis of nitric oxide: effect on hemostasis and fibrinolysis","volume":"6","author":"Schini-Kerth","year":"1999","journal-title":"Transfus. Clin. Biol."},{"key":"10.1016\/j.biopha.2023.115910_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01131","article-title":"Finerenone attenuates endothelial dysfunction and albuminuria in a chronic kidney disease model by a reduction in oxidative stress","volume":"9","author":"Gonz\u00e1lez-Bl\u00e1zquez","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115910_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40119-022-00269-3","article-title":"Cardiovascular and renal outcomes with finerenone, a selective mineralocorticoid receptor antagonist","volume":"11","author":"Palanisamy","year":"2022","journal-title":"Cardiol. Ther."},{"key":"10.1016\/j.biopha.2023.115910_bib43","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.bbamem.2016.04.015","article-title":"Alterations in plasma membrane promote overexpression and increase of sodium influx through epithelial sodium channel in hypertensive platelets","volume":"1858","author":"Cerecedo","year":"2016","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"10.1016\/j.biopha.2023.115910_bib44","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1006\/bbrc.1994.2484","article-title":"Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: subcellular localization of calcium elevations by single cell imaging","volume":"204","author":"Wehling","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.115910_bib45","article-title":"Relevance of SGK1 in structural, functional and molecular alterations produced by aldosterone in heart","volume":"18","author":"Mart\u00edn-Fern\u00e1ndez","year":"2014","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.biopha.2023.115910_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/apha.12334","article-title":"The serum- & glucocorticoid-inducible kinase in the regulation of platelet function","volume":"213","author":"Lang","year":"2015","journal-title":"Acta Physiol."},{"key":"10.1016\/j.biopha.2023.115910_bib47","doi-asserted-by":"crossref","first-page":"21876","DOI":"10.1074\/jbc.M115.657957","article-title":"Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of steroid receptor coactivator-1","volume":"290","author":"Amazit","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115910_bib48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/CS20110312","article-title":"STIM1\/Orai1 contributes to sex differences in vascular responses to calcium in spontaneously hypertensive rats","volume":"122","author":"Giachini","year":"2012","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2023.115910_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-023-01899-0","article-title":"The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction","volume":"22","author":"Kintscher","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115910_bib50","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.3390\/jcm12123992","article-title":"Finerenone: questions and answers\u2014the four fundamental arguments on the new-born promising non-steroidal mineralocorticoid receptor antagonist","volume":"12","author":"Di Lullo","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2023.115910_bib51","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/ndt\/gfac198","article-title":"Design of the combination effect of finerenone and empagliflozin in participants with chronic kidney disease and type 2 diabetes using a UACR endpoint study (CONFIDENCE)","volume":"38","author":"Green","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.biopha.2023.115910_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dsx.2020.02.012","article-title":"Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trials","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223017080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223017080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:15:48Z","timestamp":1777576548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223017080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":52,"alternative-id":["S0753332223017080"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115910","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex-dependent effects of finerenone on hemostasis in normoglycemic and streptozotocin-induced diabetic mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115910"}}